AI-Powered Neurological Screening Platform for Parkinson's Disease & Epilepsy
A comprehensive system combining wearable biosensing hardware with a mobile application for real-time neurological assessment, tremor analysis, and seizure screening.

NeuroSense is an affordable, portable neurological screening platform that combines:
Key Stats:
65 million people worldwide live with neurological disorders requiring continuous monitoring.
| Challenge | Impact |
|---|---|
| Parkinson's diagnosis delayed by 5-7 years | Late intervention, reduced quality of life |
| 30% of epilepsy patients have drug-resistant seizures | Need 24/7 monitoring unavailable to most |
| Clinical equipment costs $15,000-$50,000 | Inaccessible to underserved communities |
| Subjective clinical observation | High inter-rater variability |
Our Mission: Democratize neurological diagnostics through affordable, portable, AI-powered screening.